Coloplast A/S - Q1 2023/24 Earnings Release - Invitation for conference call on 9 February 2024 at 11.00am CET

Friday, 9 February 2024 at 11.00 - 12.00 CET
In connection with the publication of Coloplast’s interim financial results for Q1 2023/24, to be released same day around 07.30 am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.

Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Senior Director, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations

Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here

Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here

 

For more information, please contact:

Aleksandra Dimovska - Senior Director, Investor Relations
Tel.: [phone] / direct: [phone]. E-mail: [e-mail]

Kristine Husted Munk - Senior Manager, Investor Relations
Tel.: [phone] / direct: [phone]. E-mail: [e-mail]

Hannah K. Larsen - Coordinator & PA, Investor Relations
Tel.: [phone] / direct: [phone]. E-mail: [e-mail]

 

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

• Invitation for Coloplasts Q1 2023-24 conference call on 9 February 2024